Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
June 22, 2021
Reduced Oligodendrocyte Precursor Cell Impairs Astrocytic Development in Early Life Stress
Yuxin Wang, Yixun Su, Guangdan Yu, et al.
Cancers
|
February 24, 2024
Alternations of Blood Pressure Following Surgical or Drug Therapy for Prolactinomas
Yijun Cheng, Dapeng Wang, Hao Tang, et al.
Endocrine
|
January 23, 2023
DRD2 expression based on <sup>18</sup>F-fallypride PET/MR predicts the dopamine agonist resistance of prolactinomas: a pilot study
Hao Tang, Yijun Cheng, Xiaohui Lou, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
May 16, 2026
Structural and Functional Basis of SSTR5 Homodimerization in Controlling Receptor Signaling and Pasireotide Response in Corticotroph Adenomas
Hanyang Zhou, Chuanbao Li, Weiting Gu, et al.
International Journal of Biological Macromolecules
|
April 23, 2025
Host genetic variation governs PCV2 susceptibility through CXCL13 and ELK1-mediated immune regulation
Gen Liu, Yizhen Gao, Yijun Cheng, et al.
Rheumatology (Oxford, England)
|
October 17, 2020
Long non-coding RNA expression profiles in neutrophils revealed potential biomarker for prediction of renal involvement in SLE patients
Bin Cai, Jingyi Cai, Zhihua Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 24, 2006
Arsenic trioxide affects signal transducer and activator of transcription proteins through alteration of protein tyrosine kinase phosphorylation
Meir Wetzler, Michael T Brady, Erin Tracy, et al.
Acta Neuropathologica Communications
|
April 18, 2024
Therapeutic potential of targeting Nrf2 by panobinostat in pituitary neuroendocrine tumors
Yijun Cheng, Yuting Dai, Hao Tang, et al.
Neuro-Oncology
|
July 11, 2024
Targeting HTR2B suppresses nonfunctioning pituitary adenoma growth and sensitizes cabergoline treatment via inhibiting Gαq/PLC/PKCγ/STAT3 axis
Shaojian Lin, Liangbo Wang, Changxi Han, et al.
Neuro-Oncology
|
February 26, 2022
TRIM65 determines the fate of a novel subtype of pituitary neuroendocrine tumors via ubiquitination and degradation of TPIT
Hong Yao, Wanqun Xie, Yuting Dai, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
June 22, 2021
Reduced Oligodendrocyte Precursor Cell Impairs Astrocytic Development in Early Life Stress
Yuxin Wang, Yixun Su, Guangdan Yu, et al.
Cancers
|
February 24, 2024
Alternations of Blood Pressure Following Surgical or Drug Therapy for Prolactinomas
Yijun Cheng, Dapeng Wang, Hao Tang, et al.
Endocrine
|
January 23, 2023
DRD2 expression based on <sup>18</sup>F-fallypride PET/MR predicts the dopamine agonist resistance of prolactinomas: a pilot study
Hao Tang, Yijun Cheng, Xiaohui Lou, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
May 16, 2026
Structural and Functional Basis of SSTR5 Homodimerization in Controlling Receptor Signaling and Pasireotide Response in Corticotroph Adenomas
Hanyang Zhou, Chuanbao Li, Weiting Gu, et al.
International Journal of Biological Macromolecules
|
April 23, 2025
Host genetic variation governs PCV2 susceptibility through CXCL13 and ELK1-mediated immune regulation
Gen Liu, Yizhen Gao, Yijun Cheng, et al.
Rheumatology (Oxford, England)
|
October 17, 2020
Long non-coding RNA expression profiles in neutrophils revealed potential biomarker for prediction of renal involvement in SLE patients
Bin Cai, Jingyi Cai, Zhihua Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 24, 2006
Arsenic trioxide affects signal transducer and activator of transcription proteins through alteration of protein tyrosine kinase phosphorylation
Meir Wetzler, Michael T Brady, Erin Tracy, et al.
Acta Neuropathologica Communications
|
April 18, 2024
Therapeutic potential of targeting Nrf2 by panobinostat in pituitary neuroendocrine tumors
Yijun Cheng, Yuting Dai, Hao Tang, et al.
Neuro-Oncology
|
July 11, 2024
Targeting HTR2B suppresses nonfunctioning pituitary adenoma growth and sensitizes cabergoline treatment via inhibiting Gαq/PLC/PKCγ/STAT3 axis
Shaojian Lin, Liangbo Wang, Changxi Han, et al.
Neuro-Oncology
|
February 26, 2022
TRIM65 determines the fate of a novel subtype of pituitary neuroendocrine tumors via ubiquitination and degradation of TPIT
Hong Yao, Wanqun Xie, Yuting Dai, et al.
Page
of 6